Order Article Reprints

Chen P-W, Feng W-H, Ho M-Y, Su C-H, Huang S-W, Cheng C-W, Yeh H-I, Chen C-P, Huang W-C, Fang C-C, et al. P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Journal of Clinical Medicine. 2020; 9(6):1657. https://doi.org/10.3390/jcm9061657

Chen, Po-Wei, Wen-Han Feng, Ming-Yun Ho, Chun-Hung Su, Sheng-Wei Huang, Chung-Wei Cheng, Hung-I Yeh, Ching-Pei Chen, Wei-Chun Huang, Ching-Chang Fang, and et al. 2020. "P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention" Journal of Clinical Medicine 9, no. 6: 1657. https://doi.org/10.3390/jcm9061657

Chen, P.-W., Feng, W.-H., Ho, M.-Y., Su, C.-H., Huang, S.-W., Cheng, C.-W., Yeh, H.-I., Chen, C.-P., Huang, W.-C., Fang, C.-C., Lin, H.-W., Lin, S.-H., Hsieh, I.-C., & Li, Y.-H. (2020). P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Journal of Clinical Medicine, 9(6), 1657. https://doi.org/10.3390/jcm9061657